文献速递肾移植

外周血RNA测序揭示不同肾移植排斥类型的编码与非编码基因差异特征

Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection.
PubMed 文献 · Kidney Int Rep · 2020-07-26

本研究对37例活检配对的肾移植受者外周血样本进行RNA测序,比较稳定、抗体介导排斥(AMR)和T细胞介导排斥(TCMR)的转录组特征,发现102个基因可区分三种排斥表型,并在两个独立队列的62例样本中验证了SIGLEC17P假基因及其相关编码基因在AMR中高表达。

要点

  • 外周血RNA测序可识别区分AMR、TCMR和稳定移植物的基因特征。
  • 102个基因(63个编码、39个非编码)与排斥表型完美聚类,与主要组织学病变高度相关(ρ=0.91)。
  • SIGLEC17P假基因及9个相关编码基因在AMR中高表达,而在TCMR和稳定样本中不表达。

核心结论

  • 外周血中与AMR相关的关键基因特征足以将AMR与TCMR及免疫静默的移植肾区分开。

研究设计与样本

  • 发现队列纳入37例活检配对的外周血样本,包括稳定(STA)、抗体介导排斥(AMR)和T细胞介导排斥(TCMR),进行RNA测序。
  • 使用先进机器学习工具进行三向差异基因表达分析,并在2个独立肾移植队列的62例样本中通过Fluidigm验证。

主要发现

  • 发现102个基因(63个编码基因和39个非编码基因)与AMR(54个上调)、TCMR(23个上调)和STA(25个上调)相关,完美聚类并与主要组织学病变高度相关(ρ=0.91)。
  • AMR相关基因富集于内质网应激调节、适应性免疫和Ig类别转换。
  • 验证中SIGLEC17P假基因和9个SIGLEC17P相关编码基因在AMR样本中高表达,而在TCMR和STA样本中不表达。

临床怎么用

  • 外周血RNA测序基因特征有望作为无创生物标志物区分肾移植排斥类型。

局限性

  • 研究为探索性分析,样本量有限,需进一步研究验证非编码基因在排斥病理生理中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Peripheral blood (PB) molecular patterns characterizing the different effector immune pathways driving distinct kidney rejection types remain to be fully elucidated. We hypothesized that transcriptome analysis using RNA sequencing (RNAseq) in samples of kidney transplant patients would enable the identification of unique protein-coding and noncoding genes that may be able to segregate different rejection phenotypes. METHODS: We evaluated 37 biopsy-paired PB samples from the discovery cohort, with stable (STA), antibody-mediated rejection (AMR), and T cell-mediated rejection (TCMR) by RNAseq. Advanced machine learning tools were used to perform 3-way differential gene expression analysis to identify gene signatures associated with rejection. We then performed functional in silico analysis and validation by Fluidigm (San Francisco, CA) in 62 samples from 2 independent kidney transplant cohorts. RESULTS: We found 102 genes (63 coding genes and 39 noncoding genes) associated with AMR (54 upregulated), TCMR (23 upregulated), and STA (25 upregulated) perfectly clustered with each rejection phenotype and highly correlated with main histologic lesions (ρ = 0.91). For the genes associated with AMR, we found enrichment in regulation of endoplasmic reticulum stress, adaptive immunity, and Ig class-switching. In the validation, we found that the SIGLEC17P pseudogene and 9 SIGLEC17P-related coding genes were highly expressed among AMR but not in TCMR and STA samples. CONCLUSIONS: This analysis identifies a critical gene signature in PB in kidney transplant patients undergoing AMR, sufficient to differentiate them from patients with TCMR and immunologically quiescent kidney allografts. Our findings provide the basis for new studies dissecting the role of noncoding genes in the pathophysiology of kidney allograft rejection and their potential value as noninvasive biomarkers of the rejection process.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Pineda S, Sur S, Sigdel T, et al. Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection. Kidney Int Rep. 2020. PMID: 33102963. doi:10.1016/j.ekir.2020.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。